| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: | Hepatitis C virus Core NS3 + NS4 Blocking Peptide for STJ501321 is synthetically produced from the C-Term sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen Region: | C-Term |
| Specificity: | This blocking peptide is recommended for use in combination with Hepatitis C virus Core NS3 + NS4 antibody, STJ501321 |
| Immunogen: | C-epitope specific synthetic peptide corresponding to unique amino acid sequences on hepatitis C polyprotein. |
| Background | ATP binding, ATP-dependent helicase activity, Viral genome replication |
Information sourced from Uniprot.org